Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_assertion type Assertion NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_head.
- NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_assertion description "[More importantly, 15 mg/kg of INT2-31 given for 21 d via intraperitoneal injection disrupted the interaction of FAK and IGF-1R and effectively decreased phosphorylation of tumor AKT, resulting in significant melanoma tumor regression in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_provenance.
- NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_assertion evidence source_evidence_literature NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_provenance.
- NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_assertion SIO_000772 22894899 NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_provenance.
- NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_assertion wasDerivedFrom befree-2016 NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_provenance.
- NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_assertion wasGeneratedBy ECO_0000203 NP1005288.RA1eM7qFdYHZadhxeX6HEQa1PRzg58ki3XSYOaEBWkYrw130_provenance.